SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): January 21, 2003
GERON CORPORATION
| Delaware (State or Other Jurisdiction of Incorporation) |
0-20859 (Commission File Number) |
75-2287752 (IRS Employer Identification Number) |
||
| 230 Constitution Drive Menlo Park, California (Address of principal executive offices) |
94025 (Zip Code) |
(650) 473-7700
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
| Item 5. Other Events. | ||||||||
| Item 7. Exhibits. | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. Other Events.
On January 21, 2003, Geron Corporation, a Delaware corporation (the “Company”), announced that it is changing its organization in order to concentrate its resources on the continued development of its lead anti-cancer product, GRN163, and its regenerative medicine products based on human embryonic stem cells (hESCs). In the process, Geron is reducing its research staff by 29 employees and its support staff by 11 employees.
The Company’s press release announcing the organizational change is filed as an exhibit to this Current Report on Form 8-K. The summary description of the event is qualified in its entirety by reference to the document filed as an exhibit hereto.
2
Item 7. Exhibits.
| Exhibits | ||||||
| 99.1 | Press Release dated January 21, 2003. |
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GERON CORPORATION | ||||||
| Date: January 22, 2003 | By: | /s/ William D. Stempel | ||||
|
Name: Title: |
William D. Stempel Vice President and General Counsel |
|||||
4
EXHIBIT INDEX
| Exhibits | ||
| 99.1 | Press Release dated January 21, 2003 |